Raymond James Financial Services Advisors, Inc. - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 50 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Raymond James Financial Services Advisors, Inc. ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q1 2016$22,000
-18.5%
17,0000.0%0.00%
Q4 2015$27,000
+17.4%
17,0000.0%0.00%
Q3 2015$23,00017,0000.00%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q4 2015
NameSharesValueWeighting ↓
ZAZOVE ASSOCIATES LLC 83,413,000$130,650,0006.13%
AEGON USA Investment Management, LLC 6,000,000$9,368,0002.35%
MACKAY SHIELDS LLC 24,370,000$38,152,0002.07%
INCOME RESEARCH & MANAGEMENT 4,374,000$6,829,0001.11%
KINGDON CAPITAL MANAGEMENT, L.L.C. 20,000$20,347,0000.99%
SHENKMAN CAPITAL MANAGEMENT INC 5,269,000$8,264,0000.82%
Mitsubishi UFJ Securities Holdings Co., Ltd. 325,000$511,0000.76%
PALISADE CAPITAL MANAGEMENT, LP 9,299,000$14,598,0000.47%
ADVENT CAPITAL MANAGEMENT /DE/ 14,543,000$23,021,0000.35%
CSS LLC/IL 3,750,000$5,893,0000.35%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders